BKU vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BKU exhibits weak financial health with a Piotroski F-Score of just 2/9, signaling significant balance sheet and profitability concerns, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite this, the stock shows strong profitability margins and consistent analyst buy recommendations, supported by a solid dividend yield and a valuation that appears reasonable relative to peers. Earnings growth is nearly flat year-over-year, and technical indicators suggest a weak short-term trend. The current price of $47.64 sits below the analyst target of $54.09 but above the conservative Graham Number of $55.72, indicating mixed value signals.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Compare Another Pair
Related Comparisons
BKU vs BRK-B: Head-to-Head Comparison
This page compares BankUnited, Inc. (BKU) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.